170 related articles for article (PubMed ID: 33037134)
21. Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
Libera L; Craparotta I; Sahnane N; Chiaravalli AM; Mannarino L; Cerutti R; Riva C; Marchini S; Furlan D
Hum Pathol; 2018 Nov; 81():235-244. PubMed ID: 30420047
[TBL] [Abstract][Full Text] [Related]
22. Mutation profile of high-grade appendiceal mucinous neoplasm.
Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N
Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041
[TBL] [Abstract][Full Text] [Related]
23. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix.
Jiang Y; Long H; Wang W; Liu H; Tang Y; Zhang X
Pathol Oncol Res; 2011 Mar; 17(1):127-32. PubMed ID: 20640606
[TBL] [Abstract][Full Text] [Related]
25. Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database.
Kowalsky SJ; Nassour I; AlMasri S; Paniccia A; Zureikat AH; Choudry HA; Pingpank JF
Ann Surg Oncol; 2021 Dec; 28(13):8916-8925. PubMed ID: 34409541
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.
Vanderwalde A; Spetzler D; Xiao N; Gatalica Z; Marshall J
Cancer Med; 2018 Mar; 7(3):746-756. PubMed ID: 29436178
[TBL] [Abstract][Full Text] [Related]
27. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
[TBL] [Abstract][Full Text] [Related]
28. Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
Borazanci E; Millis SZ; Kimbrough J; Doll N; Von Hoff D; Ramanathan RK
J Gastrointest Oncol; 2017 Feb; 8(1):164-172. PubMed ID: 28280620
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations of GI-NECs involving three main signaling pathways.
Dai Q; Zhang J; Long W; Haybaeck J; Yang Z
Cancer Med; 2023 Apr; 12(7):8238-8250. PubMed ID: 36653904
[TBL] [Abstract][Full Text] [Related]
31. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
[TBL] [Abstract][Full Text] [Related]
32. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype.
Hsu C; Rashid A; Xing Y; Chiang YJ; Chagpar RB; Fournier KF; Chang GJ; You YN; Feig BW; Cormier JN
J Surg Oncol; 2013 Feb; 107(2):136-43. PubMed ID: 22767417
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix.
Alsaad KO; Serra S; Schmitt A; Perren A; Chetty R
Endocr Pathol; 2007; 18(1):16-22. PubMed ID: 17652796
[TBL] [Abstract][Full Text] [Related]
34. The Problem of Appendiceal Carcinoids.
Galanopoulos M; Toumpanakis C
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):661-669. PubMed ID: 30098722
[TBL] [Abstract][Full Text] [Related]
35. Goblet cell carcinoid of the appendix - diagnostic challenges and treatment updates: a case report and review of the literature.
Gilmore G; Jensen K; Saligram S; Sachdev TP; Arekapudi SR
J Med Case Rep; 2018 Sep; 12(1):275. PubMed ID: 30244681
[TBL] [Abstract][Full Text] [Related]
36. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy.
Goodman AM; Sokol ES; Frampton GM; Lippman SM; Kurzrock R
Cancer Immunol Res; 2019 Oct; 7(10):1570-1573. PubMed ID: 31405947
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
Fleming AM; Deschner BW; Williard FW; Drake JA; Vanderwalde A; Xiu J; Somer BG; Yakoub D; Tsao MW; Glazer ES; Dickson PV; Shibata D; Philip PA; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ; Deneve JL
J Surg Oncol; 2023 Apr; 127(5):815-822. PubMed ID: 36629137
[TBL] [Abstract][Full Text] [Related]
39. Appendiceal neuroendocrine neoplasms: diagnosis and management.
Alexandraki KI; Kaltsas GA; Grozinsky-Glasberg S; Chatzellis E; Grossman AB
Endocr Relat Cancer; 2016 Jan; 23(1):R27-41. PubMed ID: 26483424
[TBL] [Abstract][Full Text] [Related]
40. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.
Dimmler A; Geddert H; Faller G
Pathol Res Pract; 2014 May; 210(5):274-8. PubMed ID: 24560515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]